Two new observational studies highlight the outsized burden of cancer associated with human papillomavirus (HPV) among both ...

Compared with flu vaccine recipients, those given the RSV or shingles vaccine had 18% to 37% lower odds of receiving a ...

In its weekly update today, the US Centers for Disease Control and Prevention (CDC) reported 40 more measles cases today, ...

Shionogi will pay BioVersys $6.3 million for developing BV500, BioVersys's drug candidate for non-tuberculous mycobacteria.

Relative to before the pandemic, the number of vaccinated participants fell 10% among children and 4% in adults in pandemic ...